SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Ellis Christopher R

(Last) (First) (Middle)
45 GLOVER AVENUE
7TH FLOOR

(Street)
NORWALK CT 06850

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/01/2023
3. Issuer Name and Ticker or Trading Symbol
FACTSET RESEARCH SYSTEMS INC [ FDS ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Initiatives & P'ships
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 22,624.1869(1) D
Common Stock 450 I By Spouse
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (2) 11/03/2024 Common Stock 9,291 131.31 D
Employee Stock Option (right to buy) (3) 10/16/2025 Common Stock 7,577 165.37 D
Employee Stock Option (right to buy) (4) 11/02/2025 Common Stock 6,375 175.2 D
Employee Stock Option (right to buy) (5) 11/01/2026 Common Stock 7,606 152.28 D
Employee Stock Option (right to buy) (6) 11/02/2027 Common Stock 6,215 189.98 D
Employee Stock Option (right to buy) (7) 11/01/2028 Common Stock 4,316 221.88 D
Employee Stock Option (right to buy) (8) 11/01/2029 Common Stock 3,323 255.87 D
Employee Stock Option (right to buy) (9) 11/09/2030 Common Stock 3,196 316.71 D
Employee Stock Option (right to buy) (10) 11/01/2031 Common Stock 2,686 434.82 D
Employee Stock Option (right to buy) (11) 11/01/2032 Common Stock 2,289 426.25 D
Explanation of Responses:
1. Includes 19,700 common shares, 102 restricted stock units granted November 1, 2018 that vest 20% annually on the anniversary date of the grant and are fully vested after five years, and 2,822.1869 shares acquired through the FactSet Research Systems Inc. Employee Stock Purchase Plan.
2. Options were granted on November 3, 2014 and vest 60% on the third anniversary date of the grant and 40% on the fifth anniversary date of the grant.
3. Options were granted on October 16, 2015 and are fully vested.
4. Options were granted on November 2, 2015 and vest ratably at 20% per year over five years upon the anniversary of the date of grant.
5. Options were granted on November 1, 2016 and vest ratably at 20% per year over five years upon the anniversary of the date of grant.
6. Options were granted on November 2, 2017 and vest ratably at 20% per year over five years upon the anniversary of the date of grant.
7. Options were granted on November 1, 2018 and vest ratably at 20% per year over five years upon the anniversary of the date of grant.
8. Options were granted on November 1, 2019 and vest ratably at 20% per year over five years upon the anniversary of the date of grant.
9. Options were granted on November 9, 2020 and vest ratably at 20% per year over five years upon the anniversary of the date of grant.
10. Options were granted on November 1, 2021 and vest ratably at 20% per year over five years upon the anniversary of the date of grant.
11. Options were granted on November 1, 2022 and vest ratably at 20% per year over five years upon the anniversary of the date of grant.
Remarks:
/s/ RACHEL R. STERN, Attorney in Fact for Christopher R. Ellis 11/03/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
christopherrellispoa
POWER OF ATTORNEY KNOW ALL PEOPLE BY THESE PRESENTS, that the undersigned, Christopher R. Ellis (the “Filer”), an individual subject to the filing requirements of Section 16 of the Securities Act of 1934, as amended (the “Act”), does hereby constitute and appoint any of Linda Huber, Rachel Stern, Jeffrey Gershowitz, Jill Chavarria and Debra Quas, as Filer’s true and lawful attorney-in-fact and in Filer’s name, place and stead, to execute and deliver, and to take such other action as the attorney considers necessary or appropriate to effect, any filing on Form 3, Form 4, or Form 5 to be filed under Section 16 of the Act. IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on this 23rd day of October, 2023. /s/ Christopher R. Ellis Signature Christopher R. Ellis Printed name